Peter Olagunju - 17 Nov 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Chief Technical Officer
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
TCRR
Transactions as of
17 Nov 2022
Transactions value $
$0
Form type
4
Filing time
18 Nov 2022, 15:22:29 UTC
Previous filing
10 Dec 2021
Next filing
05 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TCRR Common Stock 2.19K 17 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -31.5K -100% $0.00* 0 17 Nov 2022 Common Stock 31.5K $12.69 Direct F1, F2
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +10.5K $0.00 10.5K 17 Nov 2022 Common Stock 10.5K Direct F2, F3, F4
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -255K -100% $0.00* 0 17 Nov 2022 Common Stock 255K $12.69 Direct F1, F5
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +84.9K $0.00 84.9K 17 Nov 2022 Common Stock 84.9K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This cancelled option vested 25% on July 26, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F2 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 10,507.
F3 Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F4 35% of these RSUs will vest December 1, 2022, 25% of these RSUs will vest on each of December 1, 2023 and December 1, 2024, and the remaining 15% of RSUs will vest on December 1, 2025.
F5 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 84,949.